Crowdberry

Crowdberry is an investment platform based in Bratislava, Slovakia, established in 2015. It specializes in providing growth capital to innovative startups and small to medium enterprises (SMEs) in Slovakia and the Czech Republic. The platform enables private investors to directly invest in a diverse range of target companies, including those in sectors such as impact investing and real estate. By connecting these companies with investors, Crowdberry aims to foster long-term value creation and support the overall growth of the domestic economy. The company is committed to principles of transparency, fairness, and mutual accountability between founders and investors.

Daniel Gašpar

Managing Partner

Michal Nespor

Partner

Michal Ondrisek

Partner

Past deals in Slovakia

GymBeam

Series A in 2020
GymBeam is a rapidly growing fitness brand based in Europe, recognized as the largest B2C eCommerce platform for fitness products in Central and Eastern Europe. The company offers a diverse range of over 500 products, including nutritional supplements, healthy foods, fitness apparel, and accessories, catering to a customer base exceeding 4.2 million. GymBeam operates from its headquarters in Germany and has a logistics and operations center in Slovakia, employing more than 160 individuals. The firm is actively expanding, particularly in marketing, logistics, IT, and data science, with a strong focus on warehouse automation and robotics to enhance operational efficiency. As an innovator in the industry, GymBeam places significant emphasis on customer and employee satisfaction, driving its commitment to quality and service in the fitness market.

MultiplexDX

Venture Round in 2018
MultiplexDX Inc. is a biotechnology diagnostics company focused on developing innovative technologies and products for the molecular diagnostic markets in North America and Central Europe. Founded in 2015 and based in Gaithersburg, Maryland, with an additional location in Slovakia, the company aims to enhance cancer diagnosis and treatment through accurate and quantifiable diagnostic tests. MultiplexDX offers RNA FISH kits and sequencing adapters for various applications, including PAR-CLIP and total RNA sequencing. The company is also advancing a new visualization technology that integrates molecular biology with histopathological methods, aiming to overcome limitations of current diagnostic practices. By providing these specialized tools and services, MultiplexDX seeks to prevent cancer misdiagnosis and improve patient outcomes, serving clients in both European and U.S. markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.